Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression as a predictor of coronary artery calcification (CAC) in patients with type 1 diabetes and nondiabetic controls. RESEARCH DESIGN AND METHODS: Insulin action was measured by a three-stage hyperinsulinemic-euglycemic clamp (4, 8, and 40 mU/m2/min) in 87 subjects from the Coronary Artery Calcification in Type 1 Diabetes cohort (40 diabetic, 47 nondiabetic; mean age 45 ± 8 years; 55% female). RESULTS: Peripheral glucose utilization was lower in subjects with type 1 diabetes compared with nondiabetic controls: glucose infusion rate (mg/kg FFM/min) = 6.19 ± 0.72 vs. 12.71 ± 0.66, mean ± SE, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and final clamp glucose and insulin. Insulin-induced NEFA suppression was also lower in type 1 diabetic compared with nondiabetic subjects: NEFA levels (μM) during 8 mU/m2/min insulin infusion = 370 ± 27 vs. 185 ± 25, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and time point insulin. Lower glucose utilization and higher NEFA levels, correlated with CAC volume (r = −0.42, P < 0.0001 and r = 0.41, P < 0.0001, respectively) and predicted the presence of CAC (odds ratio [OR] = 0.45, 95% CI = 0.22–0.93, P = 0.03; OR = 2.4, 95% CI = 1.08–5.32, P = 0.032, respectively). Insulin resistance did not correlate with GHb or continuous glucose monitoring parameters. CONCLUSIONS: Type 1 diabetic patients are insulin resistant compared with nondiabetic subjects, and the degree of resistance is not related to current glycemic control. Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Excess adiposity was associated with inadequate glycemic control in patients with T1D in the T1D Exchange study cohort.34”
From Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786 · cited 1×
“Calcium volume scores (CVS) were calculated using the volumetric method, which is based on isotropic interpolation, as previously described (40,41).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“5 hours using the method of DeFronzo et al (39).”
MethodInfluentialIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
Background(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Self-citationKrolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654 · cited 2×
“9mmol/L), (3) Hyperglycemia, percentage of glucose values >180mg/dl (10mmol/L), and (4)Glycemic variability within days, overall standard deviation (SDT), the standard deviation of all glucose values.”
Background
Cited by
Items 101–200 of 234
The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance
Alman, A. C., Smith, S. R., Eckel, R. H., Hokanson, J. E., Burkhardt, B. R., Sudini, P. R., Wu, Y., Schauer, I. E., Pereira, R. I., & Snell‐Bergeon, J. K. (2017) · Obesity · doi:10.1002/oby.21875 · Cited by 22
“Introduction While the loss of insulin production due to the antibody-mediated destruction of pancreatic beta cells is the primary pathology underlying type 1 diabetes (T1D), the presence of increased insulin resistance (IR) in both adults and children with T1D has also been demonstrated and is associated with acceler…”
BackgroundMethodResultSelf-citationSubclinical vascular disease in patients with diabetes is associated with insulin resistance
Adeva‐Andany, M. M., Funcasta-Calderón, R., Fernández‐Fernández, C., Ameneiros-Rodríguez, E., & Domínguez-Montero, A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.025 · Cited by 22
Truong, U. T., Maahs, D. M., & Daniels, S. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0018 · Cited by 28
Self-citationAdipose tissue insulin resistance in adolescents with and without type 2 diabetes
Kelsey, M. M., Forster, J. E., Pelt, R. E. V., Reusch, J. E. B., & Nadeau, K. J. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00189.x · Cited by 22
“Fasting TG are an accepted marker of IR in adults (34) and in youth (35).”
BackgroundBjornstad, P., Eckel, R. H., Pyle, L., Rewers, M., Maahs, D. M., & Snell‐Bergeon, J. K. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.07.020 · Cited by 22
“There are insufficient data on the concordance between apoB and nonHDL-C in adults with type 1 diabetes mellitus (DM) across a wide range of risk factors for atherosclerosis including triglycerides (TG) [7] and body mass indices (BMI) [8].”
BackgroundSelf-citationBarriers to Exercise in Adults With Type 1 Diabetes and Insulin Resistance
Alobaid, A. M., Zulyniak, M. A., Ajjan, R., Brož, J., Hopkins, M., & Campbell, M. D. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.016 · Cited by 22
Rozenbaum, Z., Leader, A., Neuman, Y., Shlezinger, M., Goldenberg, I., Mosseri, M., & Pereg, D. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.017 · Cited by 21
Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes
Kelsey, M. M., Bjornstad, P., McFann, K., & Nadeau, K. J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12255 · Cited by 20
Rozenbaum, Z., Benchetrit, S., Minha, S., Neuman, Y., Shlezinger, M., Goldenberg, I., Mosseri, M., & Pereg, D. (2017) · Cardiorenal Medicine · doi:10.1159/000455239 · Cited by 20
Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus
Prendergast, C., & Gidding, S. S. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0454-0 · Cited by 24
Feng, W., Li, Z., Guo, W., Fan, X., Zhou, F., Zhang, K., Ou, C., Huang, F., & Chen, M. (2020) · Diabetes Care · doi:10.2337/dc20-0838 · Cited by 19
Infante, M., Silvestri, F., Padilla, N., Pacifici, F., Pastore, D., Pinheiro, M. M., Caprio, M., Tesauro, M., Fabbri, A., Novelli, G., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041303 · Cited by 20
“In fact, insulin resistance in T1D has been linked to coronary atherosclerosis [67], cardiovascular disease, diabetic nephropathy and all-cause mortality [66,202], and it is partly driven by subcutaneously administered exogenous insulin itself [182].”
Glargine safety, diabetes and cancer
Rendell, M., Aktürk, H. K., & Tella, S. H. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.770469 · Cited by 19
Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes
Bjornstad, P., Maahs, D. M., Johnson, R. J., Rewers, M., & Snell‐Bergeon, J. K. (2014) · Diabetic Medicine · doi:10.1111/dme.12572 · Cited by 18
Self-citationJensen, T., Bjornstad, P., Johnson, R. J., Sippl, R., Rewers, M., & Snell‐Bergeon, J. K. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.03.006 · Cited by 17
“4 Estimated Insulin Sensitivity (elS): The eIS was calculated using an equation developed in a subset of the study cohort (n = 87, 40 with T1DM and 47 normal controls, frequency matched for age, gender and weight) who underwent a 3 stage hyperinsulinemic-euglycemic clamp study to measure insulin sensitivity was develo…”
MethodSelf-citationLambert, J. E., Ryan, E. A., Thomson, A. B. R., & Clandinin, M. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082530 · Cited by 16
“Insulin resistance in type 1 diabetic individuals may be more common than previously appreciated [7,8], but is difficult to assess in these individuals as it requires multi-stage clamp techniques and does not correlate with markers of glycemic control [7].”
BackgroundInfluentialMyostatin serum levels in children with type 1 diabetes mellitus
Efthymiadou, A., Vasilakis, I.-A., Giannakopoulos, A., & Chrysis, D. (2021) · HORMONES · doi:10.1007/s42000-021-00317-y · Cited by 16
Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus
Magge, S. N. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0274-9 · Cited by 16
Frampton, R., SNAITH, J. R., HOCKING, S. L., Holmes-Walker, D. J., Olsen, N., & Greenfield, J. R. (2024) · Diabetic Medicine · doi:10.1111/dme.15377 · Cited by 15
“3 We will characterise insulin resistance using hyperinsulinaemic euglycaemic clamp studies and examine whether it predicts cardiometabolic improvements.”
Wu, X., Cheong, L. Y., Yuan, L., Jin, L., Zhang, Z., Xiao, Y., Zhou, Z., Xu, A., Hoo, R. L. C., & Shu, L. (2024) · Advanced Science · doi:10.1002/advs.202308461 · Cited by 21
Rhinesmith, T., Turkette, T., & Root-Bernstein, R. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122602 · Cited by 15
Burkart, V., Straßburger, K., Zivehe, F., Markgraf, D. F., Herder, C., Müssig, K., Szendroedi, J., Schloot, N. C., Roden, M., & the GDS Group (2018) · Diabetic Medicine · doi:10.1111/dme.13608 · Cited by 15
O’Mahoney, L. L., Kietsiriroje, N., Pearson, S. M., West, D. J., Holmes, M. J., Ajjan, R., & Campbell, M. D. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01550-3 · Cited by 16
Diabetes Complications in Childhood Diabetes: New Biomarkers and Technologies
Bjornstad, P., & Maahs, D. M. (2015) · Current Pediatrics Reports · doi:10.1007/s40124-015-0081-0 · Cited by 16
Self-citationCardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences
Vurallı, D., Jalilova, L., Alikaşifoğlu, A., Özön, Z. A., Gonc, E. N., & Kandemir, N. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-12-12 · Cited by 17
Double Diabetes: A Growing Problem Requiring Solutions
Popovic, D. S., & Παπάνας, Ν. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1392-0590 · Cited by 14
Chen, Z., Li, R., Pei, L., Wei, Z., Xie, J., Wu, H., & Xu, B. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16075 · Cited by 14
Xin, Y., Zhang, J., Fan, Y., & Wang, C. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02152-w · Cited by 14
“[11] reported that a high FFA level coupled with insulin resistance can predict the extent of CAC, and may contribute to the increased risk of cardiovascular disease in patients with T1DM.”
BackgroundTell, S. S., Schäfer, M., Vigers, T., Baumgartner, A., Lyon, E., Gross, S., Polsky, S., Snell‐Bergeon, J. K., Schauer, I. E., & Nadeau, K. J. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14800 · Cited by 14
Self-citationDuvnjak, L. S., & Blaslov, K. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.012 · Cited by 14
Miller, R. G., & Costacou, T. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1240-4 · Cited by 15
Schnell, O., Valensi, P. E., Standl, E., & Ceriello, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.129 · Cited by 15
SNAITH, J. R., Narongkiatikhun, P., Bjornstad, P., Greenfield, J. R., & Tommerdahl, K. L. (2025) · Diabetes Care · doi:10.2337/dci25-0015 · Cited by 19
Herrera-Ojeda, J. L., Blanco-Palma, R. S., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02621-5 · Cited by 16
“[ 4 ].”
Yao, H., Sun, Z., Yuan, W., Shao, C., Cai, H., Li, L., Qian, Y., & Wang, Z. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s387040 · Cited by 13
SNAITH, J. R., Samocha‐Bonet, D., Evans, J., Liu, Z., Kowalski, G. M., Bruce, C. R., Holmes-Walker, D. J., & Greenfield, J. R. (2021) · Diabetic Medicine · doi:10.1111/dme.14564 · Cited by 13
Bjornstad, P., Maahs, D. M., Rewers, M., Johnson, R. J., & Snell‐Bergeon, J. K. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.017 · Cited by 13
Self-citationHenderson, M., Friedrich, M. G., Hulst, A. V., Pelletier, C., Barnett, T. A., Benedetti, A., Bigras, J., Drapeau, V., Lavoie, J., Levy, E. H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046585 · Cited by 12
Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke
Pereg, D., Rozenbaum, Z., Vorobeichik, D., Nir, S., Gilad, R., Bloch, S., Mosseri, M., & Tanné, D. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.05.003 · Cited by 12
Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
Gracheva, S. A., Klefortova, I. I., & Шамхалова, М. Ш. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5979 · Cited by 15
Insulin resistance-associated genetic variants in type 1 diabetes
Miller, R. G., McGurnaghan, S. J., Önengüt-Gümüşcü, S., Chen, W., Colhoun, H. M., Rich, S. S., Orchard, T. J., & Costacou, T. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107842 · Cited by 14
Dutta, P., Sengupta, A., & Chakraborty, S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15718-0 · Cited by 11
Liu, X., Gong, M., & Wu, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1503704 · Cited by 11
Salle, L., Julla, J., Fagherazzi, G., Gourdy, P., Parente, E. B., Hanaire, H. P., Tatulashvili, S., Disse, E., Franc, S., Hadjadj, S., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02789-3 · Cited by 13
“Additionally, insulin resistance predicted the extent of coronary calcification [39].”
Insulin Resistance and CGM-Derived Parameters in People With Type 1 Diabetes: Are They Associated?
Clinck, I., Mertens, J., Wouters, K., Dirinck, E. L., & Block, C. E. M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae015 · Cited by 13
Blaslov, K., Bulum, T., & Duvnjak, L. S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.019 · Cited by 11
“It was recently proposed that adults with T1DM have both impaired glucose utilization and impaired insulin-induced non-esterified fatty acid suppression, independent of glycemic control [7].”
BackgroundSerum C‐peptide and osteocalcin levels in children with recently diagnosed diabetes
Sabek, O. M., REDONDO, M. J., Nguyen, D. T., Beamish, C. A., Fraga, D. W., Hampe, C. S., Mulukutla, S. N., Graviss, E. A., & Gaber, A. O. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.104 · Cited by 10
Insulin resistance and coronary artery disease in non-diabetic patients: Is there any correlation?
Vafaeimanesh, J., Parham, M., Norouzi, S., Hamednasimi, P., & Bagherzadeh, M. (2018) · PubMed Central · doi:10.22088/cjim.9.2.121 · Cited by 14
“They have achieved similar results and found no association between BMI and insulin resistance (19).”
BackgroundSNAITH, J. R., Olsen, N., Evans, J., Kowalski, G. M., Bruce, C. R., Samocha‐Bonet, D., Breit, S. N., Holmes-Walker, D. J., & Greenfield, J. R. (2025) · Nature Communications · doi:10.1038/s41467-025-65951-1 · Cited by 10
Shuvy, M., Chen, S., Vorobeichik, D., Krashin, E., Nir, S., Goldenberg, I., & Pereg, D. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.053 · Cited by 10
Adiponectin-SOGA Dissociation in Type 1 Diabetes
Combs, T. P., Snell‐Bergeon, J. K., Maahs, D. M., Bergman, B. C., Lamarche, M., Iberkleid, L., AbdelBaky, O., Tisch, R., Scherer, P. E., & Marliss, E. B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1275 · Cited by 10
Self-citationYang, D., Yan, J., Deng, H., Yang, X., Luo, S., Zheng, X., Lv, J., Liang, W., Hong, M., Wu, Z., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7419345 · Cited by 12
Aberer, F., Pieber, T. R., Eckstein, M. L., Sourij, H., & Moser, O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061180 · Cited by 12
“Furthermore, insulin resistance was shown to be a more powerful predictor of coronary artery disease than glycemic control in persons with T1D [18,19].”
BackgroundHendrix, G., Lokhnygina, Y. V., Ramaker, M. E., Ilkayeva, O., Muehlbauer, M. J., Evans, W. J., Rasbach, L. E., Benjamin, R. S., Freemark, M., & Balikcioglu, P. G. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.448 · Cited by 9
Zhang, X., Xu, D., Xu, P., Yang, S., Zhang, Q., Wu, Y., & Yuan, F. (2021) · Endocrine Connections · doi:10.1530/ec-21-0146 · Cited by 13
Watso, J. C., Robinson, A. T., Singar, S., Cuba, J. N., & Koutnik, A. P. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00694.2023 · Cited by 8
Wei, X., Zhao, J., Zhu, P., Niu, W., Xu, Z., Ran, X., Zhang, X., Wang, A., & Ji, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16514 · Cited by 8
Ji, L., Lou, S., Fang, Y., Wang, X., Zhu, W., Liang, G., Lee, K.-Y., Luo, W., & Zhuang, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17050631 · Cited by 8
Determinants of Preclinical Atherosclerosis Are Different in Type 1 and Type 2 Diabetic Women
Piťhová, P., Štechová, K., Pitha, J. V., Lánská, V., & Kvapil, M. (2016) · Physiological Research · doi:10.33549/physiolres.933019 · Cited by 9
Insulin Resistance in Type 1 Diabetes: Concepts and Implications for Therapy
Bloomgarden, Z. T., & Accili, D. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70126 · Cited by 7
“Using a hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in a group of people with T1D and in non-diabetic controls, insulin resistance was associated with obesity, hypertriglyceridemia, and elevated coronary artery calcium scores [11].”
Muscle mitochondrial function is impaired in adults with type 1 diabetes
Gottlieb, D., Abushamat, L. A., Nadeau, K. J., Regensteiner, J. G., Reusch, J. E. B., Tommerdahl, K. L., Rice, J. D., Knaub, L. A., Monaco, C. M. F., Hawke, T. J., et al. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108798 · Cited by 7
Self-citationSchierloh, U. H. E., Wilinska, M. E., Cate, I. P.-T., Baumann, P. M., Hovorka, R., de Beaufort, C. E., & Spidiman Study Group: Single Port Insulin Infusion for Improved Diabetes Management (2019) · PLoS ONE · doi:10.1371/journal.pone.0212013 · Cited by 7
Vigers, T., VINOVSKIS, C. L., Li, L., Prasad, P. V., Heerspink, H. J. L., D’Alessandro, A., Reisz, J. A., Piani, F., Cherney, D. Z. I., van Raalte, D. H., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05531-3 · Cited by 7
Sammut, M. J., McBey, D. P., Sayal, A. P., & Melling, C. W. J. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5549762 · Cited by 6
Brownlee, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.015 · Cited by 6
“In T1D patients, the extent of insulin resistance, an independent risk factor for CAD in nondiabetics, predicts the extent of coronary artery calcification (Schauer et al., 2011).”
BackgroundNicoll, R., Howard, J. M., & Henein, M. Y. (2015) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v1i4.46 · Cited by 5
Coronary Calcification and Hormones
Koulaouzidis, G., & Henein, M. (2011) · Angiology · doi:10.1177/0003319711399418 · Cited by 5
Mondkar, S., Khandagale, S. B., Shah, N., Khadilkar, A. V., Oza, C. M., Bhor, S., Gondhalekar, K. M., Wagle, A. S., Kajale, N., & Khadilkar, V. V. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1353279 · Cited by 6
Marigliano, M., Schütz, Y., Piona, C. A., Tomasselli, F., Tommasi, M., Corradi, M., Olivieri, F., Fornari, E., Morandi, A., & Maffeis, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108447 · Cited by 5
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology
Frampton, R., HOCKING, S. L., SNAITH, J. R., & Greenfield, J. R. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.06.004 · Cited by 4
Metabolic Dysfunction-Associated Steatotic Liver Disease in People with Type 1 Diabetes
Vermillion, B., & Mao, Y. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155502 · Cited by 4
“Several studies have reported hepatic steatosis in lean individuals with T1D [26], suggesting that ectopic fat accumulation in this population may arise through pathways distinct from those observed in T2D.”
Blaslov, K., Bulum, T., Knežević-Ćuća, J., & Duvnjak, L. S. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.10.006 · Cited by 4
Wang, W., van Dijk, K. W., Wijsman, C. A., Rozing, M. P., Mooijaart, S. P., Beekman, M., Slagboom, P. E., Jukema, J. W., Noordam, R., & van Heemst, D. (2021) · Metabolomics · doi:10.1007/s11306-021-01806-2 · Cited by 4
“It had been shown previously that suppression of lipolysis in adipose tissue is very insulin sensitive, and differences in adipose tissue lipolysis between individuals with type 1 diabetes and healthy controls could be detected at insulin doses as low as 4 mU/m2/ min (Schauer, 2011).”
BackgroundVascular Calcification in Diabetic Kidney Disease
Phan, O., & Joki, N. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2040054 · Cited by 5
Forner, P. M., SNAITH, J. R., & Greenfield, J. R. (2023) · Internal Medicine Journal · doi:10.1111/imj.16312 · Cited by 6
Insulin sensitizer prevents and ameliorates experimental type 1 diabetes
Valitsky, M., Hoffman, A., Unterman, T. G., & Bar‐Tana, J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2016 · Cited by 4
“Thus, the CACTI study (36), in line with previous studies (14, 32), points to systemic insulin resistance in wellcontrolled T1D patients (mean Hb A1c 7.”
ResultSNAITH, J. R., & Greenfield, J. R. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51637 · Cited by 4
Type 1 Diabetes Mellitus and Exercise
Maahs, D. M., Taplin, C. E., & Fiallo-Scharer, R. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_14 · Cited by 4
Self-citationCardiovascular benefits of metformin in T1DM
Snell‐Bergeon, J. K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.116 · Cited by 4
Self-citationBailey, R. J., Sarkar, A., Snell‐Bergeon, J. K., Burkhardt, B. R., Chandrasekaran, S., Johnson, L., & Alman, A. C. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108494 · Cited by 4
Self-citationAssociation of hyperuricemia combined with sarcopenia on ASCVD risk
Nie, G., Wan, J., Jiang, L., Zhang, M., Yan, F., & Peng, W. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03336-2 · Cited by 4
Lu, G., Tang, Y., Chen, O., Guo, Y., Xiao, M., Wang, J., Liu, Q., Li, J., Gao, T., Zhang, X., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.025 · Cited by 3
Type 1 Diabetes Mellitus and Dyslipidemia
Maahs, D. M., & Eckel, R. H. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_7 · Cited by 4
Self-citationMuscle insulin resistance in type 1 diabetes with coronary artery disease
Williams, K. V., Shay, C. M., Price, J. C., Goodpaster, B. H., Kelley, C. A., Kelley, D. E., & Orchard, T. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05270-w · Cited by 3
Type 1 Diabetes Mellitus and Exercise
Roberts, A. J. C., Forlenza, G. P., Maahs, D. M., & Taplin, C. E. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_19 · Cited by 4
Self-citationNovel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients
Naciu, A. M., & Pozzilli, P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1441288 · Cited by 3
Coronary artery calcification in type 1 diabetes after 10-year ketogenic diet
Koutnik, A. P., Lennerz, B. S., Deeb, L. C., & Watso, J. C. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2025 · Cited by 2
Serum Dipeptidyl peptidase-4 level is related to adiposity in type 1 diabetic adolescents
Ibrahim, A., Salah, S., Attia, M., Madani, H. A., Ahmad, S., Arafa, N., & Soliman, H. M. A. L. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.003 · Cited by 2
Miętkiewska-Dolecka, M., & Uruska, A. A. (2021) · Journal of Medical Science · doi:10.20883/medical.e531 · Cited by 2
Cardiovascular mortality post burn injury
Paratz, J. D., Warren, J., Paratz, E. D., Watt, K., Corte-Real, V., Müller, M. J., & Cameron, C. M. (2022) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003781 · Cited by 2
Acipimox in Type 1 Diabetes: fatty acids as a potential, but challenging, therapeutic target
Kaput, K. L., Lyon, E., & Schauer, I. E. (2024) · Medical Research Archives · doi:10.18103/mra.v12i12.6170 · Cited by 2
Self-citationBelmadani, S., & Matrougui, K. (2014) · Diabetes · doi:10.2337/db14-1366 · Cited by 2
SNAITH, J. R., Holmes-Walker, D. J., & Greenfield, J. R. (2019) · Diabetes Care · doi:10.2337/dc19-0730 · Cited by 2
Braffett, B. H., Dagogo-Jack, S. E., Bebu, I., Sivitz, W. I., Larkin, M., Kolterman, O., & Lachin, J. M. (2019) · Diabetes Care · doi:10.2337/dci19-0026 · Cited by 2
Petrelli, A., Ravà, L., Mascali, A., Rapini, N., Massoud, M., Bitti, M. L. M., Cianfarani, S., & Manco, M. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3479 · Cited by 1
“These findings are consistent withprevious reports showing reduced IS in normal‐weight T1D patients with optimised glycaemic control.(5,21) Patients with optimal glycaemic control over the previous 10 years had better eIS, body composition, lipid profile and interestingly, required less insulin as compared to patients…”
ResultAlSaihati, H., Ahmed, B. Y., Mosaad, R. M., El-Garhy, H. A. S., Bakeer, R. M., Yousef, E. M., Ahmed, I. M., Nasr, W. S. S. E., Shadidizaji, A., Ahmed-Farid, O. A.-H., et al. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70382 · Cited by 1
Estimated glucose disposal rate and risk of first myocardial infarction in people with diabetes
Glynn, L., Persson, M., Andersson, T., Hofmann, R., & Nyström, T. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00294-4 · Cited by 1
Childhood-onset Type 1 diabetes and cardiovascular disease
Perchard, R., & Amin, R. (2015) · Diabetes Management · doi:10.2217/dmt.14.61 · Cited by 1
TYPE 2 DIABETES MELLITUS AND CORONARY HEART DISEASE
Bardymova, T. P., Протасов, К. В., TSYRETOROVA, S., & Сергеевна, Д. О. (2017) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.12737/article_5955e6b60d5bf2.66416553 · Cited by 1
Double diabetes: the cardiovascular implications of combining type 1 with type 2 diabetes
Cleland, S. (2017) · Practical Diabetes · doi:10.1002/pdi.2120 · Cited by 1
Metadata
- Authors
- Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M.
- Affiliations
- University of Colorado Anschutz (US)
- Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Denver, Aurora, Colorado.
- Corresponding author
- Schauer, Irene E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 60
- Issue
- 1
- Pages
- 306-314
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012187
- OpenAlex
- W2140420590
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 11 · 2021: 23 · 2020: 13 · 2019: 15 · 2018: 11 · 2017: 19 · 2016: 9 · 2015: 24 · 2014: 17 · 2013: 13 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (BIRCWH K12 Program, P30 DK)
- National Heart, Lung, and Blood Institute (R01HL113029, HL61753, R01HL61753, R01HL061753, R01HL079611)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516)
- National Center for Research Resources (M01RR000051)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin resistance, type 1 diabetes, coronary artery calcification, free fatty acids, peripheral glucose utilization, hyperinsulinemic-euglycemic clamp, cardiovascular risk, glycemic control, HbA1c, continuous glucose monitoring, atherosclerosis, diabetic cardiomyopathy, dyslipidemia, dyslipoproteinemia
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Calcium, Coronary Vessels, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Environmental Monitoring, Fatty Acids, Fatty Acids, Nonesterified, Female, Glycerol, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Reference Values, Spleen, Tomography, X-Ray Computed, Glucose Clamp Technique, Cohort Studies, Absorptiometry, Photon, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.